| |
|
|
|
Galectin Therapeutics Inc.  
|
|
3.38 -0.01 (-0%) |
08-21 16:00 |
|
Open: |
3.49 |
Pre close: |
3.39 |
Target:
|
4.32
|
|
High: |
3.47 |
Low: |
3.33 |
Resistance:
|
3.70
4.03
|
|
Volume: |
197,076 |
Market Cap: |
191M |
Support:
|
3.16
2.63
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.38
 |
MACD |
MACD(12,26):
|
-0.13 |
|
MA(20): |
3.49  |
Signal(12,26,9): |
-0.13 |
|
MA(100): |
4.10 |
Stochastic Oscillator |
%K(14,3):
|
32.45 |
|
MA(250): |
4.61 |
%D(3): |
31.24 |
|
Average Volume(K) |
3-Month: |
32469
|
52-Week |
High:
|
6.98 |
|
10-Days: |
26805 |
Low: |
3.16 |
|
RSI |
RSI(14):
|
41.06 |
Change(%): |
-27.2 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.418 |
Return on Equity (ttm) |
-36.4 |
Shares Out. (M) |
37.57 |
|
EPS Est. Current Year |
-0.530 |
Return on Assets (ttm) |
-21.5 |
Shares Float (M) |
41.01 |
|
EPS Est. Next Year |
-0.520 |
PEG Ratio |
0.00 |
% Held by Insiders |
24.55 |
|
EPS Est. Next Quarter |
-0.130 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
12.63 |
|
Forward EPS |
-0.690 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
3800 |
|
Book Value (p.s.) |
0.870 |
EBITDA (p.s.) |
0.000 |
P/E |
-8.09 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
3.89 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-9.20 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-4.61 |
P/CF |
-13.80 |
|
|
|
|
|
|
